Omega-3

Amarin Pharma Inc., maker of high-concentration EPA-only omega-3 drug Vascepa, has reached a settlement with omega-3 dietary supplement companies The Coromega Company, Inc., and Omax Health, Inc over complaints the drug company filed in October of 2018.

Here’s what the latest research shows about five of the market’s fastest-growing cognitive performance ingredients.

Amarin, maker of the omega-3 drug Vascepa, has failed in its attempt to get an investigation launched against several omega-3 dietary supplement products and suppliers.

A study recently published in Circulation is challenging our understanding about the effect high levels of omega-6 fatty acids have on human health. 

A recent study published in The Journal of Nutrition shows that fish oil supplementation during the third trimester of pregnancy increased gestational age, size of gestational age, and the birth weight of infants. 

The Global Organization for EPA and DHA Omega-3s (GOED) has launched the GOED Proud Member logo. 

The European Medicines Agency (EMA) has confirmed its previous recommendation to no longer recommend the use of omega-3 fatty acids for secondary prevention of myocardial infarction, following a request for re-examination.

The heart health category remains important to the dietary supplement industry because it includes a stable of products that have proven efficacy and consistent usage.

Researchers determined that an absolute decrease in 1% of Omega-3 Index was associated with 39% greater odds of PAD.

Lycored will be developing a new formulation combining its Lycomato lycopene with omega-3 fatty acids. 

OmegaQuant Analytics is offering free Omega-3 Index tests at Natural Products Expo West booth #4568 where they are colocated with Wiley’s Finest. 

The single-use format makes it easy and convenient for consumers to carry their omega-3 supplements on the go.

The botanicals market is seeing a number of new entrants and emerging stars quickly gaining ground.

Market research indicates that today’s consumers are spending more on immune-health supplements than ever. Ahead, a look at some of the latest studies on immune-health ingredients.

According to the report, the global omega-3 sector grew 1.8% between 2016 and 2017, to become a $1.29 billion industry, experiencing its third straight year of growth.

OmegaQuant Analytics, the producer of The Omega-3 Index, has launched a new Prenatal DHA Test developed for expecting mothers to monitor their omega-3 DHA level. 

The omega-3 industry will continue its efforts to overcome unfairly negative messaging about omega-3 ingredients and to highlight positive findings.

The company now operates two krill trawlers in Antarctica.

The researchers found that a high serum dihomo-γ-linolenic acid (DGLA), an omega-6 polyunsaturated fatty acid, was associated with obesity, body fat accumulation, a high alanine amino transferase level, and insulin resistance in Japanese subjects with type 2 diabetes.

Researchers have discovered two novel anti-inflammatory compounds that are converted from eicosatetraenoic acid (ETA), a long-chain omega-3 fatty acid elevated by the consumption of Ahiflower oil.

New research finds that krill oil may significantly reduce fasting blood glucose. 

The European Medicines Agency (EMA) will no longer authorize omega-3 fatty acids for secondary prevention of myocardial infarction, based on an eight-month review of research.

The Global Organization for EPA and DHA Omega-3 (GOED; Salt Lake City, UT) has issued two industry advisories addressing technical concerns related to omega-3 fatty acids EPA and DHA: one regarding micro- and nanoplastic particle contamination, and a second addressing the correct expression of EPA, DHA, and total omega-3 fatty acid content in oils.

New study contradicts theory that omega-3 fish oil can increase risk of bleeding in surgical patients.

Aker BioMarine provides updates on its research efforts in the areas of sports nutrition and lupus. 

Although researchers did not find a reduction in the primary endpoint of significantly reducing major CVD events, the study did reveal some positive, statistically significant benefits, the association says.

Amarin Pharma Inc., maker of high-concentration EPA-only omega-3 drug Vascepa, has filed false advertising lawsuits against two omega-3 dietary supplement manufacturers: Coromega Health Inc. and Omax Health Inc. 

The Global Organization for EPA and DHA Omega-3s has released a new industry advisory for how to properly express the content of omega-3 fatty acids EPA, DHA, and other fatty acids in oils. 

Not only do 75% of Americans take supplements, but 87% of U.S. adults have overall confidence in the safety, quality, and effectiveness of dietary supplement products, the survey found.

It is well known that EPA and DHA support cardiovascular and metabolic health through several mechanisms.